DAHLBECK SCOTT (Chief Medical Officer) received a stock award from KIROMIC BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/15/2022ACC: 0001104659-22-091245
Officer· Chief Medical Officer
Since Oct 2020
+50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
11.2%
8/11/2022
446.76K→496.76K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/11/2022 | A · Award | +50K | — | — | 11.2% | 446.76K | 496.76K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported